CTI BioPharma gets Israel's approval for sale of cancer drug

CTI BioPharma Corp. has won approval from Israeli officials to distribute its Pixuvri drug for certain patients with cancer in Israel...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.